- Report
- October 2024
- 70 Pages
Europe
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
China
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
France
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Germany
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
India
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
Japan
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United Kingdom
From €865EUR$950USD£734GBP
- Report
- October 2024
- 70 Pages
United States
From €865EUR$950USD£734GBP
- Report
- July 2024
- 280 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- July 2024
- 280 Pages
Global
From €1692EUR$1,859USD£1,437GBP
€2416EUR$2,655USD£2,052GBP
- Report
- June 2023
- 277 Pages
Global
From €2351EUR$2,583USD£1,997GBP
€3359EUR$3,690USD£2,853GBP
- Book
- December 2023
- 464 Pages
- Book
- December 2013
- 328 Pages

The Artificial Organ market is a subset of the Biomaterials industry, which focuses on the development of materials for use in medical applications. Artificial organs are designed to replace or supplement the function of a damaged or missing organ, and can be made from a variety of materials, including polymers, metals, and ceramics. These materials are chosen for their biocompatibility, durability, and ability to interact with the body's natural systems.
The Artificial Organ market is driven by advances in medical technology, as well as the increasing prevalence of chronic diseases and organ failure. The market is expected to grow in the coming years, as more people seek out treatments for their conditions.
Companies in the Artificial Organ market include Abiomed, SynCardia Systems, and WorldHeart Corporation. Show Less Read more